Promising new pancreatic cancer treatment
Image credit: nci via Unsplash
A groundbreaking new pancreatic cancer treatment has shown the potential to significantly improve patient outcomes, with early studies reporting survival times that are nearly twice as long as those seen with current standard therapies. Researchers describe the findings as a major step forward in a disease that has historically been difficult to treat. While additional studies are needed to confirm long-term benefits, the results offer new hope for patients and highlight the rapid progress being made in precision cancer medicine.
Source
O'Reilly, E. M., Wainberg, Z. A., Hendifar, A. E., Borad, M. J., Pietrantonio, F., Pant, S., Hammel, P., Cremolini, C., Manji, G. A., Oberstein, P. E., Garrido-Laguna, I., Springfeld, C., Azad, N. S., Ueno, M., Chui, S. Y., Zhang, Y., Patel, H., Lee, Y., Salman, Z., Wolpin, B. M., … RASolute 302 Trial Investigators (2026). Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer. The New England journal of medicine, 10.1056/NEJMoa2605555. Advance online publication. https://doi.org/10.1056/NEJMoa2605555
Additional Reading
https://www.cbsnews.com/news/pancreatic-cancer-treatment-daraxonrasib-survival-rate/